10x Genomics
TXG
TXG
303 hedge funds and large institutions have $9.38B invested in 10x Genomics in 2020 Q4 according to their latest regulatory filings, with 123 funds opening new positions, 105 increasing their positions, 58 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $8.54B → $9.38B (+$842M)
8.13% less ownership
Funds ownership: 90.76% → 82.63% (-8.1%)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Holders
303
Holding in Top 10
10
Calls
$27.5M
Puts
$8.82M
Top Buyers
| 1 | +$265M | |
| 2 | +$210M | |
| 3 | +$182M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$85.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$72M |
Top Sellers
| 1 | -$892M | |
| 2 | -$425M | |
| 3 | -$314M | |
| 4 |
FCMI
Foresite Capital Management I
Larkspur,
California
|
-$212M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$159M |